Literature DB >> 27590500

Phosphoinositide 3-kinase/protein kinase B/periostin mediated platelet-derived growth factor-induced cell proliferation and extracellular matrix production in lupus nephritis.

Xue Zhao1,2, Jun Hao1, Huijun Duan1, Zanhua Rong2, Fan Li1.   

Abstract

In the present study, the effect and mechanism of periostin on renal proliferation and extracellular matrix accumulation of lupus mice were investigated. MRL /lpr mice, known as lupus mice, were revealed to show enhanced periostin, proliferating cell nuclear antigen (PCNA), and extracellular matrix accumulation in the kidney accompanied by increased serum platelet-derived growth factor (PDGF). Again, cultured mouse mesangial cells (MMCs) were treated with PDGF, then periostin, and PCNA and secreted fibronectin were detected. The results showed that intracellular periostin and PCNA were respectively enhanced by 2.691 and 2.308 times in PDGF-treated MMC cells at 6 h after stimulation. In addition, secreted fibronectin was increased by 1.442 times. Next, the transfection of periostin shRNA vector in PDGF-stimulated MMC cells effectively suppressed periostin, PCNA and secreted fibronectin by 45.27%, 47.75%, and 39.95%, compared with PDGF-stimulated cells transfected with control vector. Furthermore, it was found that PDGF increased the expression of phospho-Akt (Ser 473) from 30 min to 6 h in MMCs. LY294002 effectively inhibited phospho-Akt (Ser 473) expression caused by PDGF stimulation. Then, periostin, PCNA, and fibronectin were respectively decreased by 69.61%, 46.00%, and 46.20%. In the end, phosphoinositide 3-kinase/protein kinase B/periostin was suggested to mediate PDGF-induced cell proliferation and extracellular matrix production in lupus nephritis.

Entities:  

Keywords:  Periostin; extracellular matrix; lupus nephritis; phosphoinositide 3-kinase/protein kinase B; platelet-derived growth factor; proliferating cell nuclear antigen

Mesh:

Substances:

Year:  2016        PMID: 27590500      PMCID: PMC5167113          DOI: 10.1177/1535370216668050

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  25 in total

1.  Immunocytochemical detection of phosphatidylinositol 3-kinase activation by insulin and leptin.

Authors:  Kevin D Niswender; Byron Gallis; James E Blevins; Marshall A Corson; Michael W Schwartz; Denis G Baskin
Journal:  J Histochem Cytochem       Date:  2003-03       Impact factor: 2.479

Review 2.  The pathology of lupus nephritis.

Authors:  Melvin M Schwartz
Journal:  Semin Nephrol       Date:  2007-01       Impact factor: 5.299

3.  Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility.

Authors:  Lindsay Gillan; Daniela Matei; David A Fishman; C S Gerbin; Beth Y Karlan; David D Chang
Journal:  Cancer Res       Date:  2002-09-15       Impact factor: 12.701

Review 4.  Periostin, a multifunctional matricellular protein in inflammatory and tumor microenvironments.

Authors:  Allan Yi Liu; Hong Zheng; Gaoliang Ouyang
Journal:  Matrix Biol       Date:  2014-05-09       Impact factor: 11.583

5.  Periostin induces intracellular cross-talk between kinases and hyaluronan in atrioventricular valvulogenesis.

Authors:  Shibnath Ghatak; Suniti Misra; Russell A Norris; Ricardo A Moreno-Rodriguez; Stanley Hoffman; Robert A Levine; Vincent C Hascall; Roger R Markwald
Journal:  J Biol Chem       Date:  2014-01-27       Impact factor: 5.157

Review 6.  Cartilage oligomeric matrix protein and its binding partners in the cartilage extracellular matrix: interaction, regulation and role in chondrogenesis.

Authors:  Chitrangada Acharya; Jasper H N Yik; Ashleen Kishore; Victoria Van Dinh; Paul E Di Cesare; Dominik R Haudenschild
Journal:  Matrix Biol       Date:  2014-07-02       Impact factor: 11.583

7.  Corneal dystrophy-associated R124H mutation disrupts TGFBI interaction with Periostin and causes mislocalization to the lysosome.

Authors:  Bong-Yoon Kim; James A Olzmann; Seung-Il Choi; So Yeon Ahn; Tae-Im Kim; Hyun-Soo Cho; Hwal Suh; Eung Kweon Kim
Journal:  J Biol Chem       Date:  2009-05-28       Impact factor: 5.157

Review 8.  Periostin in fibrillogenesis for tissue regeneration: periostin actions inside and outside the cell.

Authors:  Akira Kudo
Journal:  Cell Mol Life Sci       Date:  2011-08-11       Impact factor: 9.261

9.  Fibronectin peptides that bind PDGF-BB enhance survival of cells and tissue under stress.

Authors:  Fubao Lin; Jia Zhu; Marcia G Tonnesen; Breena R Taira; Steve A McClain; Adam J Singer; Richard A F Clark
Journal:  J Invest Dermatol       Date:  2013-10-14       Impact factor: 8.551

10.  Periostin localizes to cells in normal skin, but is associated with the extracellular matrix during wound repair.

Authors:  Linda Jackson-Boeters; Weiyan Wen; Douglas W Hamilton
Journal:  J Cell Commun Signal       Date:  2009-06-19       Impact factor: 5.782

View more
  12 in total

Review 1.  New Insights on Platelets and Platelet-Derived Microparticles in Systemic Lupus Erythematosus.

Authors:  Marc Scherlinger; Vanja Sisirak; Christophe Richez; Estibaliz Lazaro; Pierre Duffau; Patrick Blanco
Journal:  Curr Rheumatol Rep       Date:  2017-08       Impact factor: 4.592

2.  Novel Targets for Therapy of Renal Fibrosis.

Authors:  Niki Prakoura; Juliette Hadchouel; Christos Chatziantoniou
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

3.  Periostin Promotes Cell Proliferation and Macrophage Polarization to Drive Repair after AKI.

Authors:  Raphaёl Kormann; Panagiotis Kavvadas; Sandrine Placier; Sophie Vandermeersch; Aude Dorison; Jean-Claude Dussaule; Christos E Chadjichristos; Niki Prakoura; Christos Chatziantoniou
Journal:  J Am Soc Nephrol       Date:  2019-11-05       Impact factor: 10.121

Review 4.  Periostin in kidney diseases.

Authors:  Niki Prakoura; Christos Chatziantoniou
Journal:  Cell Mol Life Sci       Date:  2017-09-07       Impact factor: 9.261

5.  An Adaptogen: Withaferin A Ameliorates in Vitro and in Vivo Pulmonary Fibrosis by Modulating the Interplay of Fibrotic, Matricelluar Proteins, and Cytokines.

Authors:  Swarna Bale; Pooladanda Venkatesh; Manoj Sunkoju; Chandraiah Godugu
Journal:  Front Pharmacol       Date:  2018-03-22       Impact factor: 5.810

Review 6.  Periostin and Discoidin Domain Receptor 1: New Biomarkers or Targets for Therapy of Renal Disease.

Authors:  Niki Prakoura; Christos Chatziantoniou
Journal:  Front Med (Lausanne)       Date:  2017-05-09

7.  Development of an engineered peptide antagonist against periostin to overcome doxorubicin resistance in breast cancer.

Authors:  Khine Kyaw Oo; Thanpawee Kamolhan; Anish Soni; Suyanee Thongchot; Chalermchai Mitrpant; Pornchai O-Charoenrat; Chanitra Thuwajit; Peti Thuwajit
Journal:  BMC Cancer       Date:  2021-01-14       Impact factor: 4.430

8.  Periostin Secreted by Carcinoma-Associated Fibroblasts Promotes Ovarian Cancer Cell Platinum Resistance Through the PI3K/Akt Signaling Pathway.

Authors:  Lei Chu; Fangce Wang; Wenjun Zhang; Huai-Fang Li; Jun Xu; Xiao-Wen Tong
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

9.  Immunomodulatory Effects of Diet and Nutrients in Systemic Lupus Erythematosus (SLE): A Systematic Review.

Authors:  Md Asiful Islam; Shahad Saif Khandker; Przemysław J Kotyla; Rosline Hassan
Journal:  Front Immunol       Date:  2020-07-22       Impact factor: 7.561

Review 10.  Anti-double Stranded DNA Antibodies: Origin, Pathogenicity, and Targeted Therapies.

Authors:  Xiaoyu Wang; Yumin Xia
Journal:  Front Immunol       Date:  2019-07-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.